Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Yann, Meslier"'
Autor:
Sandrine Delignat, Yann Meslier, Olivier D. Christophe, Yohann Repessé, Ana-Maria Navarrete, Sébastien Lacroix-Desmazes, Nimesh Gupta, Srini V. Kaveri
Publikováno v:
Haemophilia. 18:248-254
The development of inhibitory anti-factor VIII (FVIII) antibodies in patients with haemophilia A following replacement therapy is associated with several types of risk factors. Among these, the purity of FVIII concentrates, and in particular the pres
Autor:
Sébastien Lacroix-Desmazes, Yann Meslier, Srinivas V. Kaveri, Sébastien André, Maud Teyssandier
Publikováno v:
Immunology. 131:549-555
Replacement therapy with exogenous factor VIII (FVIII) to treat haemorrhages or used in prophylaxis induces inhibitory anti-FVIII immunoglobulin G (IgG) in some patients with haemophilia A. Therapeutic strategies to prevent the onset of the deleterio
Autor:
Sune Justesen, Maxime Lecerf, Sébastien Lacroix-Desmazes, Roberto Mallone, Jordan D. Dimitrov, David W. Scott, Yann Meslier, Valérie Gouilleux-Gruart, Srinivas V. Kaveri, Slobodan Culina, Bagirath Gangadharan, Christophe Arnoult, Nimesh Gupta, Benoît L. Salomon, Sandrine Delignat
Publikováno v:
Science Translational Medicine
Science Translational Medicine, American Association for the Advancement of Science, 2015, 7 (275), pp.275ra21-275ra21. ⟨10.1126/scitranslmed.aaa1957⟩
Science Translational Medicine, 2015, 7 (275), pp.275ra21-275ra21. ⟨10.1126/scitranslmed.aaa1957⟩
Science Translational Medicine, American Association for the Advancement of Science, 2015, 7 (275), pp.275ra21-275ra21. ⟨10.1126/scitranslmed.aaa1957⟩
Science Translational Medicine, 2015, 7 (275), pp.275ra21-275ra21. ⟨10.1126/scitranslmed.aaa1957⟩
International audience; Central tolerance plays a key role in modulating immune responses to self and exogenous antigens. The absence of self-antigen expression, as in patients with genetic deficiencies, prevents the development of antigen-specific i
Autor:
Yann Meslier, Srini V. Kaveri, Sébastien André, Jordan D. Dimitrov, Sébastien Lacroix-Desmazes, Jagadeesh Bayry, Sandrine Delignat
Publikováno v:
Journal of Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis, Wiley, 2011, 9 (4), pp.719-728. ⟨10.1111/j.1538-7836.2011.04200.x⟩
Journal of Thrombosis and Haemostasis, 2011, 9 (4), pp.719-728. ⟨10.1111/j.1538-7836.2011.04200.x⟩
Journal of Thrombosis and Haemostasis, Wiley, 2011, 9 (4), pp.719-728. ⟨10.1111/j.1538-7836.2011.04200.x⟩
Journal of Thrombosis and Haemostasis, 2011, 9 (4), pp.719-728. ⟨10.1111/j.1538-7836.2011.04200.x⟩
Summary. Background: Replacement therapy with exogenous factor VIII to treat hemorrhages induces inhibitory anti-FVIII antibodies in up to 30% of patients with hemophilia A. Current approaches to eradicate FVIII inhibitors using high-dose FVIII injec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3738d549887d9f97f133d12bfb869b07
https://www.hal.inserm.fr/inserm-02455569
https://www.hal.inserm.fr/inserm-02455569
Autor:
Yann, Meslier, Sébastien, André, Maud, Teyssandier, Srinivas V, Kaveri, Sébastien, Lacroix-Desmazes
Publikováno v:
Immunology. 131(4)
Replacement therapy with exogenous factor VIII (FVIII) to treat haemorrhages or used in prophylaxis induces inhibitory anti-FVIII immunoglobulin G (IgG) in some patients with haemophilia A. Therapeutic strategies to prevent the onset of the deleterio
Autor:
Marc Jacquemin, Srini V. Kaveri, Cyril Planchais, Sébastien André, Jean-Marie Saint-Remy, Jordan D. Dimitrov, D Saboulard, Lubka T. Roumenina, Boris P. Atanasov, Sébastien Lacroix-Desmazes, Yann Meslier, Jean-Luc Plantier
Publikováno v:
Journal of thrombosis and haemostasis : JTH. 8(7)
Summary. Background: BO2C11 is a human monoclonal factor (F) VIII inhibitor. When bound to the C2 domain of FVIII, the Fab fragment of BO2C11 (FabBO2C11) buries a surface of C2 that contains residues participating in a binding site for von Willebrand
Autor:
Yann Meslier, Sébastien Lacroix-Desmazes, Jordan D. Dimitrov, Yohann Repessé, Sébastien André, Suryasarathi Dasgupta, Srinivas V. Kaveri
Publikováno v:
Clinical reviews in allergyimmunology. 37(2)
A large proportion of hemophilia A patients who receive replacement therapy, develop an immune response toward the infused factor VIII (FVIII). In this review, we discuss recent progress in several aspects of the anti-FVIII immune response, focusing
Autor:
Maud Teyssandier, Sébastien André, Ana-Maria Navarrete, Srini V. Kaveri, Yann Meslier, Frédéric Triebel, Sandrine Delignat, Sébastien Lacroix-Desmazes, Jagadeesh Bayry
Publikováno v:
Arthritis & Rheumatism. 60:2848-2849